PMID- 38375727
OWN - NLM
STAT- MEDLINE
DCOM- 20240221
LR  - 20240221
IS  - 2284-0729 (Electronic)
IS  - 1128-3602 (Linking)
VI  - 28
IP  - 3
DP  - 2024 Feb
TI  - Efficacy of high-frequency chest wall oscillations vs. lung flute in chronic 
      obstructive pulmonary disease patients with post-COVID.
PG  - 1227-1233
LID - 35361 [pii]
LID - 10.26355/eurrev_202402_35361 [doi]
AB  - OBJECTIVE: In chronic obstructive pulmonary disease (COPD), high-frequency chest 
      wall oscillations (HFCWO) and lung flute (LF) are used to improve COPD patients' 
      pulmonary functions, exertional dyspnea, as well as life quality. This 
      comparative study aimed to assess the efficiency of HFCWO vs. LF in 
      post-coronavirus-disease (COVID) men with COPD. PATIENTS AND METHODS: Sixty 
      post-COVID men with COPD, who were aged 40-60 years old, were included in this 
      HFCWO-vs.-LF comparative study and were divided into two groups. One group (N=30) 
      received HFCWO, and the other group (N=30) received LF three times per week. Both 
      groups' pulmonary functions, including forced vital capacity (FVC), forced 
      expiratory volume at the first second (FEV1), the ratio of FEV1/FVC (FEV1/FVC), 
      forced expiratory flow between 25% and 75% of the pulmonary volume (FEF25-75%) 
      were assessed. Also, the COPD assessment test score (CAT score) and 6-minute walk 
      distance (6MWD) were measured before and following the trial. RESULTS: Regarding 
      all variables (post-COVID patients' FVC, FEV1, FEV1/FVC, FEF25-75%, CAT score, as 
      well as 6MWD), both groups had substantial changes after the three-week 
      HFCWO-vs.-LF interventional period as the p-value was below 0.05. The changes in 
      post-COVID patients' FEV1, FEV1/FVC, and 6MWD were high in the HFCWO group, while 
      the changes in post-COVID patients' CAT score, FVC, and FEF25-75% were high in 
      the LF group. CONCLUSIONS: HFCWO is more efficient than the LF in improving 
      pulmonary functions and exertional dyspnea in post-COVID men with COPD.
FAU - Mahmoud Ahmed, O S
AU  - Mahmoud Ahmed OS
AD  - Department of Physical Therapy for Internal Medicine and Geriatrics, Faculty of 
      Physical Therapy, October University for Modern Sciences and Arts (MSA), 6th 
      October City, Giza, Egypt. omniasaeedmahmoud2021@gmail.com.
FAU - Abd El-Rahim Abd El-Aty, S
AU  - Abd El-Rahim Abd El-Aty S
FAU - Ahmed El-Hadidy, H
AU  - Ahmed El-Hadidy H
FAU - Mohamed Abdelhakiem, N
AU  - Mohamed Abdelhakiem N
FAU - Mohamed El-Moatasem, A
AU  - Mohamed El-Moatasem A
LA  - eng
PT  - Journal Article
PL  - Italy
TA  - Eur Rev Med Pharmacol Sci
JT  - European review for medical and pharmacological sciences
JID - 9717360
SB  - IM
MH  - Male
MH  - Humans
MH  - Adult
MH  - Middle Aged
MH  - *Chest Wall Oscillation
MH  - *COVID-19
MH  - Lung
MH  - *Pulmonary Disease, Chronic Obstructive
MH  - Vital Capacity
MH  - Forced Expiratory Volume
MH  - Dyspnea/etiology
EDAT- 2024/02/20 11:50
MHDA- 2024/02/21 11:22
CRDT- 2024/02/20 05:33
PHST- 2024/02/21 11:22 [medline]
PHST- 2024/02/20 11:50 [pubmed]
PHST- 2024/02/20 05:33 [entrez]
AID - 35361 [pii]
AID - 10.26355/eurrev_202402_35361 [doi]
PST - ppublish
SO  - Eur Rev Med Pharmacol Sci. 2024 Feb;28(3):1227-1233. doi: 
      10.26355/eurrev_202402_35361.